About the Familial Cancer Session
Familial cancer refers to cancers that occur more frequently within families due to shared genetic mutations. Understanding the genetic basis of familial cancer is crucial for cancer research, as it helps identify individuals at higher risk and allows for tailored prevention and treatment strategies. Researchers study familial cancer syndromes to uncover specific genetic alterations that predispose individuals to certain types of cancer, such as BRCA1 and BRCA2 mutations in breast and ovarian cancer. By elucidating these genetic factors, scientists can develop targeted therapies and screening protocols to detect cancer at earlier stages, potentially saving lives. Moreover, studying familial cancer sheds light on broader mechanisms of carcinogenesis, offering insights into the molecular pathways underlying various cancer types and driving advancements in precision medicine.
Topics Covered in Familial Cancer
Cancer Predisposition Genes
Germline Genetic Testing
Genetic Counseling
Pedigree Risk Assessment
Risk-Reducing Surgery
Enhanced Surveillance
Related Scientific Sessions at CIOC 2027
Why Attend the Familial Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Familial Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Familial Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Familial Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Familial Cancer Conference 2027 — FAQs
What is the Familial Cancer track at CIOC 2027?
The Familial Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Familial Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Familial Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Familial Cancer are all welcome — whether presenting or attending.
Can I present my research in the Familial Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Familial Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Familial Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.